RESUMEN
OBJECTIVE: To examine the association of viruses with acute febrile respiratory disease in horses. Design Nasal swab and serum samples were collected from 20 horses with acute febrile upper respiratory disease that was clinically assessed to have a viral origin. METHODS: Each of the samples was inoculated onto equine fetal kidney, RK13 and Vero cell cultures, and viral nucleic acid was extracted for polymerase chain reaction (PCR) or reverse transcription PCR. PCR primers were designed to amplify nucleic acid from viruses known to cause or be associated with acute febrile respiratory disease in horses in Australia. A type specific ELISA was used to measure equine herpesvirus (EHV1 and EHV4) antibody, and serum neutralisation assays were used to measure equine rhinitis A virus (ERAV) and equine rhinitis B virus 1 and 2 (ERBV1 and ERBV2) antibody titres in serum samples. RESULTS: Virus was isolated from 4 of 20 nasal swab samples. There were three isolations of EHV4 and one of ERBV2. By PCR, virus was identified in the nasal swab samples of 12 of the 20 horses. Of the 12 horses [corrected] that were positive, 17 viruses were detected as follows: there was [corrected] one triple positive (EHV4, EHV2, and EHV5), three double positives (EHV4, ERBV and EHV5, ERBV (2 horses)) and 8 [corrected] single positives (EHV4 (2 horses), EHV5 (3 horses) and ERBV (3 [corrected] horses). CONCLUSION: By virus isolation and PCR, 17 viruses were identified in nasal swab samples from 12 of 20 horses that had acute febrile respiratory disease consistent with a diagnosis of virus infection. Initial PCR identification and subsequent virus isolation led to the isolation of ERBV2 for the first time in Australia and the second time anywhere of ERBV2.
Asunto(s)
Infecciones por Herpesviridae/veterinaria , Enfermedades de los Caballos/diagnóstico , Cavidad Nasal/virología , Infecciones por Picornaviridae/veterinaria , Picornaviridae/aislamiento & purificación , Infecciones del Sistema Respiratorio/veterinaria , Varicellovirus/aislamiento & purificación , Animales , Aphthovirus/aislamiento & purificación , Erbovirus/aislamiento & purificación , Infecciones por Herpesviridae/diagnóstico , Infecciones por Herpesviridae/virología , Herpesvirus Équido 1/aislamiento & purificación , Herpesvirus Équido 4/aislamiento & purificación , Enfermedades de los Caballos/virología , Caballos , Infecciones por Picornaviridae/diagnóstico , Infecciones por Picornaviridae/virología , Reacción en Cadena de la Polimerasa/métodos , Reacción en Cadena de la Polimerasa/veterinaria , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/virología , Pruebas Serológicas/veterinariaRESUMEN
Five of 10 pregnant, lactating mares, each with a foal at foot, developed neurological disease. Three of them became recumbent, developed complications and were euthanased; of the two that survived, one aborted an equine herpesvirus type 1 (EHV-1)-positive fetus 68 days after the first signs were observed in the index case and the other gave birth to a healthy foal on day 283 but remained ataxic and incontinent. The diagnosis of EHV-1 myeloencephalitis was supported by postmortem findings, PCR identification of the virus and by serological tests with an EHV-1-specific ELISA. At the time of the index case, the 10 foals all had a heavy mucopurulent nasal discharge, and PCR and the ELISA were used to detect and monitor EHV-1 infection in them. The status of EHV-1 infection in the five in-contact mares was similarly monitored. Sera from three of the affected mares, taken seven days after the index case were negative or had borderline EHV-1-specific antibody titres. In later serum samples there was an increase in the titres of EHV-1-specific antibody in two of the affected mares. In contrast, sera from the five unaffected in-contact mares were all EHV-1-antibody positive when they were first tested seven or 13 days after the index case.
Asunto(s)
Anticuerpos Antivirales/análisis , Brotes de Enfermedades/veterinaria , Encefalomielitis/veterinaria , Infecciones por Herpesviridae/veterinaria , Herpesvirus Équido 1/inmunología , Enfermedades de los Caballos/epidemiología , Complicaciones Infecciosas del Embarazo/veterinaria , Aborto Veterinario/epidemiología , Animales , Animales Recién Nacidos , Anticuerpos Antivirales/sangre , Ataxia/etiología , Ataxia/veterinaria , Encefalomielitis/complicaciones , Encefalomielitis/epidemiología , Ensayo de Inmunoadsorción Enzimática/veterinaria , Femenino , Infecciones por Herpesviridae/complicaciones , Infecciones por Herpesviridae/epidemiología , Herpesvirus Équido 1/genética , Herpesvirus Équido 1/aislamiento & purificación , Enfermedades de los Caballos/sangre , Enfermedades de los Caballos/virología , Caballos , Inmunohistoquímica/veterinaria , Masculino , Reacción en Cadena de la Polimerasa/veterinaria , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Victoria/epidemiologíaRESUMEN
OBJECTIVE: To develop rapid (< 8 hour) tests using polymerase chain reaction (PCR) for the diagnosis of equine herpesvirus 3 (EHV3; equine coital exanthema virus), equine gammaherpesviruses 2 (EHV2) and EHV5, equine adenovirus 1 (EAdV1), EAdV2, equine arteritis virus (EAV), equine rhinitis A virus (ERAV; formerly equine rhinovirus 1) DESIGN: Either single round or second round (seminested) PCRs were developed and validated. METHODS: Oligonucleotide primers were designed that were specific for each virus, PCR conditions were defined and the specificity and sensitivity of the assays were determined. The application of the tests was validated using a number of independent virus isolates for most of the viruses studied. The PCRs were applied directly to clinical samples where samples were available. RESULTS: We developed a single round PCR for the diagnosis of EHV3, a seminested PCR for EHV2 and single round PCRs for EHV5, EAdV1, EAdV2 and RT-PCRs for EAV and ERAV. The PCR primer sets for each virus were designed and shown to be highly specific (did not amplify any recognised non-target template) and sensitive (detection of minimal amounts of virus) and, where multiple virus isolates were available all isolates were detected. CONCLUSION: The development and validation of a comprehensive panel of PCR diagnostic tests, predominantly for viruses causing equine respiratory disease, that can be completed within 8 hours from receipt of clinical samples, provides a major advance in the rapid diagnosis or exclusion diagnosis of these endemic equine virus diseases in Australia.
Asunto(s)
Enfermedades de los Caballos/diagnóstico , Infecciones del Sistema Respiratorio/veterinaria , Virosis/veterinaria , Virus/aislamiento & purificación , Adenoviridae/genética , Adenoviridae/aislamiento & purificación , Animales , Aphthovirus/clasificación , Aphthovirus/genética , Aphthovirus/aislamiento & purificación , Secuencia de Bases , Cartilla de ADN , Equartevirus/clasificación , Equartevirus/genética , Equartevirus/aislamiento & purificación , Herpesvirus Équido 3/clasificación , Herpesvirus Équido 3/genética , Herpesvirus Équido 3/aislamiento & purificación , Enfermedades de los Caballos/virología , Caballos , Reacción en Cadena de la Polimerasa/veterinaria , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/virología , Rhadinovirus/clasificación , Rhadinovirus/genética , Rhadinovirus/aislamiento & purificación , Sensibilidad y Especificidad , Virosis/diagnóstico , Virosis/virología , Virus/clasificación , Virus/genéticaRESUMEN
OBJECTIVE: To develop and validate specific, sensitive and rapid (< 8 hour) diagnostic tests using polymerase chain reaction (PCR) for the diagnosis of abortion and respiratory disease caused by equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus). DESIGN: Primer sets based on nucleotide sequences encoding glycoprotein H (gH) of EHV1 and gB of EHV4 were designed and used in single round and second round (seminested) PCRs, and in a multiplex PCR for the diagnosis of EHV1 and EHV4 infections. METHODS: Oligonucleotide primers were designed for each virus, PCR conditions were defined and the specificity and sensitivity of the assays were determined. The tests were applied to tissue samples from aborted equine foetuses and to nasopharyngeal swabs from horses with acute febrile respiratory disease. RESULTS: Individual single round and a second round (seminested) EHV1 and EHV4 PCRs were specific in that EHV1 primers amplified all (n = 30) EHV1 isolates and did not amplify EHV4. Similarly EHV4 primers amplified all (n = 6) EHV4 isolates and did not amplify EHV1. Both PCRs were sensitive in that the first round EHV1 PCR detected 1220 molecules of EHV1 plasmid DNA and the first round EHV4 PCR detected 7280 molecules of EHV4 plasmid DNA. The EHV1 second round PCR was 100 times more sensitive in that it detected 12 molecules of EHV1 DNA and the EHV4 second round PCR was 1000 times more sensitive in that it detected 8 molecules of EHV4 DNA. There was a high correlation between detection of EHV1 by virus isolation and PCR when tissue samples from 71 aborted foetuses were examined; all samples positive by virus isolation were positive by PCR. Similarly the EHV4 PCR was at least as sensitive as virus isolation when applied to nasaopharyngeal swabs from horses with respiratory disease in that all samples positive by virus isolation were also positive by PCR. CONCLUSION: Individual single round and second round (seminested) PCRs and a seminested multiplex PCR were developed that enabled reliable, rapid detection of EHV1 and EHV4 in aborted foetal tissues and nasopharyngeal swab samples.
Asunto(s)
ADN Viral/aislamiento & purificación , Infecciones por Herpesviridae/veterinaria , Herpesvirus Équido 1/aislamiento & purificación , Herpesvirus Équido 4/aislamiento & purificación , Enfermedades de los Caballos/diagnóstico , Infecciones del Sistema Respiratorio/veterinaria , Aborto Veterinario/etiología , Animales , Southern Blotting/veterinaria , Cartilla de ADN , Femenino , Feto/virología , Infecciones por Herpesviridae/complicaciones , Infecciones por Herpesviridae/diagnóstico , Enfermedades de los Caballos/virología , Caballos , Nasofaringe/virología , Reacción en Cadena de la Polimerasa/normas , Reacción en Cadena de la Polimerasa/veterinaria , Embarazo , Infecciones del Sistema Respiratorio/complicaciones , Infecciones del Sistema Respiratorio/diagnóstico , Sensibilidad y EspecificidadRESUMEN
A head-group modified, photoreactive analog of phosphatidylethanolamine, N-([125I]iodo-4-azidosalicy- lamidyl)-1,2-dilauryl-sn-glycero-3-phosphatidylethanolamine ([125I]-N-ASA-DLPE), has been used in photoaffinity labeling studies of proteins of the human erythrocyte membrane. [125I]-N-ASA-DLPE was shown to be preferentially incorporated into a protein with an apparent molecular weight of 31 kDa. Protein sequencing and immunoprecipitation were used to identify this protein as the erythrocyte membrane protein, band 7.2b or stomatin. A sulphydryl-reactive ligand, 4-hydroxy-3-(iodo-[125I])-N-[2-(2-pyridinyldithio)ethyl]- benzenepropanamide ([125I]-PDA), was also shown to preferentially label band 7.2b. We propose that band 7.2b may act as a site of transbilayer reorientation of membrane phospholipids.